Back

Transcatheter aortic valve replacement in bicuspid aortic valve patients

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology Aortic Valve Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fernando Nascimento Ferreira

Hospital de Santa Marta, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Left ventricular cardiac recovery and reverse remodeling in patients with aortic stenosis after TAVI: a systematic review and meta-analysis
Doctor E. Hasabo (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Screening for amyloidosis in patients scheduled for aortic valve replacement
Doctor I. Mattig (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement
Doctor N. Vaxelaire (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Valve-in-valve transcatheter aortic valve implantation in patients with failed bioprosthetic aortic valves: an analysis of safety, feasibility and clinical outcomes.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Differences in outcomes between percutaneous coronary intervention of bystander coronary lesions and medical therapy in patients undergoing transcatheter aortic valve implantation
Doctor R. Carvalheiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of outcomes between TAVI and SAVR in patients with bicuspid aortic valve stenosis
thumbnail
Congress Presentation
Valve dysfunction in patients with bicuspid aortic stenosis undergoing surgical aortic valve replacement versus transcatheter aortic valve replacement
thumbnail
Congress Presentation
TAVI is safe and effective for the treatment of bicuspid aortic valve stenosis: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources